BIOMARIN PHARMACEUTICAL INC Accrued Marketing Costs, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Accrued Marketing Costs, Current of $55.96 million as of 2019-09-30, per its 10-Q/A filed 2019-11-04.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedMarketingCostsCurrent · last filed 2019-11-04
- 2019-09-30: Accrued Marketing Costs, Current $55.96M.
- 2019-06-30: Accrued Marketing Costs, Current $49.18M.
- 2019-03-31: Accrued Marketing Costs, Current $46.11M.
- 2018-12-31: Accrued Marketing Costs, Current $43.12M.
| Period end | Accrued Marketing Costs, Current |
|---|---|
| 2019-09-30 | $55.96M 10-Q/A · filed 2019-11-04 |
| 2019-06-30 | $49.18M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $46.11M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $43.12M 10-Q/A · filed 2019-11-04 |
| 2018-09-30 | $42.35M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $50.94M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $38.45M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $36.47M 10-K · filed 2019-02-28 |
| 2017-09-30 | $38.32M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $37.97M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $36.16M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $34.74M 10-K · filed 2018-02-26 |
| 2016-09-30 | $34.18M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $32.63M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $34.16M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $32.55M 10-K · filed 2017-02-27 |
| 2015-09-30 | $27.36M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $29.49M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $17.17M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $14.86M 10-K · filed 2016-02-29 |
| 2014-09-30 | $13.71M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $11.98M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $10.76M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $10.43M 10-K · filed 2015-03-02 |
| 2013-09-30 | $10.15M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $10.71M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $8.67M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $9.63M 10-K · filed 2014-02-26 |
| 2012-09-30 | $8.96M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $6.00M 10-Q · filed 2012-08-02 |
| 2011-12-31 | $6.03M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |